Live
- VIP Treatment: Exclusive Benefits for High Rollers in Online Casino
- LS polls: Union Minister Bhagwanth Khuba, Dingaleshwara seer, Priyanka Jarkiholi file nominations in K'taka
- Amid show of strength, Congress’ Praniti Shinde files nomination from Solapur
- Tamil Nadu Police gives clean report to Isha Foundation in missing volunteers case
- Home Minister Amit Shah to address public meeting in Goa on April 24
- Gurgaon Open: M Dharma fires 67 for two-shot lead on penultimate day
- Sharad Pawar made many attempts to finish Shiv Sena, claims Maha minister
- Former England opener Raman Subba Row dies aged 92
- IPL 2024: Impact player rule is affecting the progress of half all-rounders, says Zaheer Khan
- ‘Teppa samudram’ review: Entertains with twists and turns
Hetero Labs arm acquires Spanish firm
Hetero, one of Indias leading generic pharmaceutical companies and the worlds largest producer of antiretroviral drugs, announced on Wednesday that its European subsidiary Amarox Limited has acquired Tarbis Farma, a company operating in Spain from Grupo Ferrer Internacional
Hyderabad: Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced on Wednesday that its European subsidiary Amarox Limited has acquired Tarbis Farma, a company operating in Spain from Grupo Ferrer Internacional.
Tarbis Farma comes with a robust product portfolio and an extensive marketing network with well-experienced personnel in retail business across Spain. The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio, manpower and a seamless entry into the retail, hospital and Tender business channels in Spain.
A V Narasa Reddy, ED, Hetero Labs Limited, stated that this acquisition fits very well with Hetero’s growth strategy in EU giving Amarox a platform to reach out to the customers in a robust way with the present portfolio and Hetero’s pipeline
of products.
